Stocktoria
ICON PLC ICLR
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 1998-05-15
ICON PLC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $8.3B | $8.2B | $8.1B | $7.7B | $5.5B |
| SG&A expense | $780.1M | $728.3M | $768.6M | $778.8M | $585.3M |
| Operating income | $442.8M | $1.0B | $904.7M | $795.2M | $378.5M |
| Interest expense | — | — | $336.7M | $229.7M | $182.4M |
| Income tax | $23.1M | $64.6M | $18.4M | $59.4M | $41.3M |
| Net income | $229.3M | $739.1M | $554.2M | $505.3M | $153.2M |
| EPS (diluted) | $2.90 | $8.90 | $6.70 | $6.13 | $2.25 |
| Operating cash flow | $1.0B | $1.3B | $1.2B | $563.3M | $829.1M |
| Free cash flow | $862.0M | $1.1B | $1.0B | $421.2M | $735.4M |
| Cash & equivalents | $647.3M | $538.8M | $378.1M | $288.8M | $752.2M |
| Inventory | — | — | — | — | $5.8M |
| Total assets | $16.3B | $16.6B | $16.9B | $17.2B | $17.4B |
| Total liabilities | $7.1B | $7.2B | $7.7B | $8.7B | $9.3B |
| Shareholders' equity | $9.2B | $9.4B | $9.2B | $8.5B | $8.1B |
Source: SEC EDGAR filings · CIK 0001060955 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.